Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PDEX
Upturn stock ratingUpturn stock rating

Pro-Dex Inc (PDEX)

Upturn stock ratingUpturn stock rating
$44.88
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: PDEX (3-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

rating

1 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Year Target Price $56

Year Target Price $56

Analyst’s Price TargetsFor last 52 week
$56Target price
Low$16.84
Current$44.88
high$70.26

Analysis of Past Performance

Type Stock
Historic Profit 55.98%
Avg. Invested days 33
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 146.36M USD
Price to earnings Ratio 16.26
1Y Target Price 56
Price to earnings Ratio 16.26
1Y Target Price 56
Volume (30-day avg) -
Beta 0.18
52 Weeks Range 16.84 - 70.26
Updated Date 06/29/2025
52 Weeks Range 16.84 - 70.26
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 2.76

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 14.61%
Operating Margin (TTM) 20.9%

Management Effectiveness

Return on Assets (TTM) 12.73%
Return on Equity (TTM) 28.29%

Valuation

Trailing PE 16.26
Forward PE 18.87
Enterprise Value 155567609
Price to Sales(TTM) 2.28
Enterprise Value 155567609
Price to Sales(TTM) 2.28
Enterprise Value to Revenue 2.43
Enterprise Value to EBITDA 10.83
Shares Outstanding 3261040
Shares Floating 1815651
Shares Outstanding 3261040
Shares Floating 1815651
Percent Insiders 35.95
Percent Institutions 29.95

Analyst Ratings

Rating 5
Target Price 56
Buy -
Strong Buy 1
Buy -
Strong Buy 1
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Pro-Dex Inc

stock logo

Company Overview

overview logo History and Background

Pro-Dex, Inc. was founded in 1978. It initially focused on contract manufacturing for various industries. Over time, it has evolved to specialize in the design, development, and manufacturing of powered surgical instruments, primarily for orthopedic surgeons.

business area logo Core Business Areas

  • Powered Surgical Instruments: Designs, develops, manufactures, and markets powered surgical instruments used primarily in orthopedic surgery. These instruments include drills, saws, reamers, and other specialized tools.
  • Other Contract Manufacturing: Provides contract manufacturing services for other industries, though this segment is smaller than the powered surgical instruments segment.

leadership logo Leadership and Structure

Richard Van Kirk serves as President and CEO. The company has a board of directors overseeing its operations and strategic direction.

Top Products and Market Share

overview logo Key Offerings

  • High-Speed Surgical Drills: High-speed surgical drills used in orthopedic procedures. Market share data for specific drill models is not publicly available, but Pro-Dex is a niche player in the broader powered surgical instrument market. Competitors include Stryker, Johnson & Johnson (DePuy Synthes), and Medtronic.
  • Specialized Surgical Saws: Specialized surgical saws designed for precise bone cutting. Similar to drills, specific market share figures are not readily available. Competitors also include Stryker, Johnson & Johnson (DePuy Synthes), and Medtronic.

Market Dynamics

industry overview logo Industry Overview

The powered surgical instrument market is driven by factors such as an aging population, increasing demand for minimally invasive surgery, and technological advancements. The market is competitive, with several large players and smaller niche companies.

Positioning

Pro-Dex is a niche player focused on high-precision surgical instruments. Its competitive advantage lies in its ability to design and manufacture custom instruments for specific surgical applications.

Total Addressable Market (TAM)

The global powered surgical instruments market is estimated to be in the billions of dollars. Pro-Dex, as a niche player, addresses a segment of this TAM with its specialized products.

Upturn SWOT Analysis

Strengths

  • Specialized expertise in powered surgical instruments
  • Strong design and manufacturing capabilities
  • Focus on niche markets
  • Ability to develop custom instruments

Weaknesses

  • Smaller size and scale compared to larger competitors
  • Limited marketing and distribution resources
  • Concentration of revenue in a few key products

Opportunities

  • Expanding into new surgical specialties
  • Developing innovative instrument designs
  • Partnering with larger medical device companies
  • Growth in minimally invasive surgery

Threats

  • Competition from larger medical device companies
  • Technological advancements that could render existing products obsolete
  • Pricing pressures from hospitals and healthcare providers
  • Regulatory changes in the medical device industry

Competitors and Market Share

competitor logo Key Competitors

  • STRY
  • JNJ
  • MDT
  • SYK

Competitive Landscape

Pro-Dex competes with larger players in the powered surgical instrument market. It differentiates itself through its specialization in niche applications and custom instrument design. However, its smaller size limits its marketing and distribution reach compared to its larger competitors.

Major Acquisitions

Custom Machining, Inc

  • Year: 2019
  • Acquisition Price (USD millions): 3.5
  • Strategic Rationale: Expanded manufacturing capabilities and product offerings.

Growth Trajectory and Initiatives

Historical Growth: Growth trends would need to be determined by analyzing historical financial data.

Future Projections: Future projections can be found in analyst reports or company presentations.

Recent Initiatives: Recent strategic initiatives would require real-time access to company announcements and press releases.

Summary

Pro-Dex is a niche player in the powered surgical instrument market with strengths in specialized design and manufacturing. Its smaller size and limited resources present challenges. The company's ability to capitalize on growth opportunities in minimally invasive surgery and partnerships will be critical for its future success. Competition from larger medical device companies remains a significant threat.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Website
  • Industry Reports
  • Market Research

Disclaimers:

This analysis is based on publicly available information and is not financial advice. Market share data is estimated. Always consult with a financial professional before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Pro-Dex Inc

Exchange NASDAQ
Headquaters Irvine, CA, United States
IPO Launch date 1995-08-18
CEO, President & Director Mr. Richard Lee Van Kirk Jr.
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 146
Full time employees 146

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.